Scynexis (SCYX) Common Equity (2013 - 2026)
Scynexis' (SCYX) quarterly Common Equity came in at $64000.0 in Q1 2026, down 99.87% YoY from $50.5 million in Q1 2025, and up 39.13% on a QoQ basis from $46000.0 in Q4 2025.
Scynexis (SCYX) Common Equity (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 14 years of Common Equity data on file, last reported at $64000.0 in Q1 2026.
- Quarterly Common Equity fell 99.87% year-over-year to $64000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64000.0 (down 99.87% YoY) and the FY2025 annual result came in at $46000.0, down 99.92% from the prior year.
- Common Equity advanced to $64000.0 in Q1 2026, from $46000.0 in the prior quarter.
- In the past five years, Common Equity ranged from a high of $93.1 million in Q2 2023 to a low of -$29.9 million in Q1 2023.
- A 5-year average of $39.8 million and a median of $45.5 million in 2022 frame the typical range for Common Equity.
- The widest YoY moves for Common Equity: up 2156.79% in 2023, down 176.85% in 2023.
- Tracing SCYX's Common Equity over 5 years: stood at $3.2 million in 2022, then surged by 2156.79% to $73.0 million in 2023, then dropped by 24.51% to $55.1 million in 2024, then sank by 99.92% to $46000.0 in 2025, then jumped by 39.13% to $64000.0 in 2026.
- The last three Common Equity figures came in at $64000.0 (Q1 2026), $46000.0 (Q4 2025), and $45000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 4.05 Bn |
| 10 | Scynexis | 62.02 Mn | -52.68 Mn | - | 66.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 66.93 Mn |
| Mar 31, 2026 | 64,000.00 |
| Dec 31, 2025 | 46,000.00 |
| Sep 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 44.47 Mn |
| Mar 31, 2025 | 50.53 Mn |
| Dec 31, 2024 | 55.08 Mn |
| Sep 30, 2024 | 58.53 Mn |
| Jun 30, 2024 | 60.41 Mn |
| Mar 31, 2024 | 74.11 Mn |
| Dec 31, 2023 | 72.96 Mn |
| Sep 30, 2023 | 91.99 Mn |
| Jun 30, 2023 | 93.08 Mn |
| Mar 31, 2023 | -29.91 Mn |
| Dec 31, 2022 | 3.23 Mn |
| Sep 30, 2022 | 17.21 Mn |
| Jun 30, 2022 | 45.48 Mn |
| Mar 31, 2022 | 38.93 Mn |
| Dec 31, 2021 | 41.26 Mn |
| Sep 30, 2021 | 37.61 Mn |